Ivermectin Cuts Covid Mortality by 92%, Major Study Finds – Why is it Still Not Approved?
Regular use of ivermectin led to a 100% reduction in hospitalisation and a 92% reduction in mortality from COVID-19, a major new study has found. Why is it still not approved?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed